Generated by AI
Processa Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation chemotherapy and other therapies for serious diseases with high unmet medical needs. The company’s current portfolio centers on oncology programs designed to improve the safety and efficacy of existing cancer treatments by modifying how approved drugs are metabolized and distributed while preserving their cancer-killing mechanisms. Its pipeline also includes non-oncology candidates for conditions such as gastroparesis and glomerular disease. Processa Pharmaceuticals uses a regulatory science-driven approach to advance drug candidates that aim to offer better treatment options for patients facing complex medical conditions. Headquartered in Vero Beach, Florida, Processa Pharmaceuticals participates in the broader pharmaceutical innovation market through research, clinical development, and product pipeline advancement.
Website601 21st Street
Vero Beach, FL, 32960
United States
The latest articles about PCSA.
VERO BEACH, FL, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company advancing differentiated therapeutic programs for immunological and inflammatory diseases, today announced its participation in two upcoming conferences. Sheila Gujrathi, M.D., Executive Chair of Processa’s Board of Directors, will participate in a fireside chat at the UBS Global Healthcare Conference on Monday, November 16, at 4 p
VERO BEACH, FL, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company advancing differentiated therapeutic programs for immunological and inflammatory diseases, today announced key leadership appointments to support the Company’s next phase of growth: Gregory J. Flesher, Chief Operating OfficerCraig Coburn, Ph.D., Executive Vice President, Head of ResearchAshley Hall, J.D., Executive Vice President,
Summary of Oct 9's posts. Generated by AI.
Summary of Jul 29's posts. Generated by AI.
Summary of Oct 9's posts. Generated by AI.
Investors talking about PCSA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.